Walleye Trading LLC Akero Therapeutics, Inc. Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $5,587 - $24,712	491 Added 0.42%	116,054 $2.71 Million
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $2.81 Million - $3.56 Million	68,112 Added 143.54%	115,563 $5.85 Million
Q2 2023 Aug 14, 2023	BUY	$36.89 - $56.88 $1.41 Million - $2.17 Million	38,186 Added 412.15%	47,451 $2.22 Million
Q1 2023 May 15, 2023	SELL	$37.27 - $50.24 $932,607 - $1.26 Million	-25,023 Reduced 72.98%	9,265 $354,000
Q4 2022 Feb 14, 2023	BUY	$33.44 - $54.8 $717,455 - $1.18 Million	21,455 Added 167.19%	34,288 $1.88 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $130,254 - $436,963	12,833 New	12,833 $437,000

190

74.6M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.51B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.